Bioequivalence Study of UHAC62XX Tablets Compared With Capsules in Healthy Volunteers

Inclusion Criteria: * Age \>= 20 and \<= 35 years * Weight: Body Mass Index \>= 18.5 and \< 25 * Subjects who are judged by the investigator to be appropriate as the subjects of the study based on results of screening test * Subjects who volunteer to participate and are able to fully understand and agree with this study by written informed consent Exclusion Criteria: * History of gastrointestinal ulcer or surgery of gastrointestinal tract (except appendectomy) * History of hypersensitivity to UHAC 62 XX and/or salicylate (aspirin etc.) and/or Non-steroidal anti-inflammatory drugs (NSAIDs) * History of aspirin induced asthma (bronchial asthma induced by NSAIDs) * History of bleeding tendency * History of alcohol or drug abuse * Participation to another trial with an investigational drug within 4 months prior to the trial * Whole blood donation more than 400 ml within 3 months prior to the trial * Whole blood donation more than 100 ml within 1 month prior to the trial * Donation of constituent of blood of more than 400 ml within 1 month prior to the trial * Any medication which might influence the results of the trial within 10 days prior to the trial * Excessive physical activities within 7 days prior to the trial * Alcohol drinking within 3 days prior to the trial * History of orthostatic hypotension, fainting spells or blackouts * Other than above, those who are judged by the investigator to be inappropriate as the subjects of the study